EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Melatonin Activates KEAP1/NRF2/PTGS2 Pathway to Attenuate Hyperoxia-Driven Ferroptosis in Bronchopulmonary Dysplasia

Xianhui Deng, Anni Xie, Danni Ye, Yizhe Ma, Zhidan Bao, Qiuyan Xie, Zichen Luo, Ran Wang, Hu Li, Renqiang Yu iD

Journal of Inflammation Research · 2025-06 · Volume 18 · 7571-7583

DOI: 10.2147/jir.s520404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inflammation Research, 2025-06. Verfasst von Xianhui Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Jiangyin People's Hospital, Wuxi, People's Republic of China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purposes: Ferroptosis, a type of regulated cell death, has been confirmed to play a role in the pathogenesis of bronchopulmonary dysplasia (BPD). This study aimed to test the hypothesis that melatonin mitigates hyperoxia-induced BPD by inhibiting ferroptosis in alveolar epithelial cells, specifically through modulation of the KEAP1/NRF2/PTGS2 signaling pathway.

Methods

Hyperoxia-induced MLE-12 cells and neonatal mice were used to establish BPD models. The effects of melatonin on hyperoxia-induced ferroptosis in MLE-12 cells were assessed by administering melatonin and ferroptosis inducer erastin to these cells. Key target genes involved in melatonin's ameliorative effects on BPD were identified using bioinformatics analysis. To confirm the regulatory relationship between melatonin and the KEAP1/NRF2/PTGS2 pathway, MLE-12 cells were treated with the NRF2 inhibitor ML385 under hyperoxic conditions. Additionally, molecular docking was performed to predict interactions between melatonin and KEAP1.

Results

Melatonin (MT) treatment up-regulated the expression of glutathione peroxidase 4 (GPX4) and xCT in hyperoxia-treated alveolar epithelial cells. The anti-ferroptosis effect of MT on these cells was significantly reduced by ML385, confirming the role of the KEAP1/NRF2 pathway in MT's mechanism of action. In vivo experiments demonstrated that MT up-regulated NRF2, GPX4, and xCT levels and down-regulated KEAP1 and PTGS2 levels in hyperoxia-induced BPD models.

Conclusion

Melatonin exerts a protective effect against hyperoxia-induced BPD by inhibiting ferroptosis in alveolar epithelial cells, and this effect is mediated, at least in part, through the KEAP1/NRF2/PTGS2 axis.

Schlagwörter

Stichwörter der Autor:innen

KEAP1NRF2PTGS2bronchopulmonary dysplasiaferroptosismelatonin

Autor:innen und Institutionen

  • Department of Neonatology, Jiangyin People's Hospital, Wuxi, People's Republic of China.
  • Department of Neonatology, Affiliated Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, People's Republic of China.

ORCID-Profile: Renqiang Yu

Zitieren

APA

Deng, X., Xie, A., Ye, D., Ma, Y., Bao, Z., Xie, Q., Luo, Z., Wang, R., Li, H., & Yu, R. (2025). Melatonin Activates KEAP1/NRF2/PTGS2 Pathway to Attenuate Hyperoxia-Driven Ferroptosis in Bronchopulmonary Dysplasia. Journal of Inflammation Research, Volume 18, 7571-7583. https://doi.org/10.2147/jir.s520404

Vancouver

Deng X, Xie A, Ye D, Ma Y, Bao Z, Xie Q, et al. Melatonin Activates KEAP1/NRF2/PTGS2 Pathway to Attenuate Hyperoxia-Driven Ferroptosis in Bronchopulmonary Dysplasia. Journal of Inflammation Research. 2025;Volume 18:7571-7583. doi:10.2147/jir.s520404

BibTeX
@article{Deng2025,
  author = {Deng, Xianhui and Xie, Anni and Ye, Danni and Ma, Yizhe and Bao, Zhidan and Xie, Qiuyan and Luo, Zichen and Wang, Ran and Li, Hu and Yu, Renqiang},
  title = {Melatonin Activates KEAP1/NRF2/PTGS2 Pathway to Attenuate Hyperoxia-Driven Ferroptosis in Bronchopulmonary Dysplasia},
  journal = {Journal of Inflammation Research},
  year = {2025},
  volume = {Volume 18},
  pages = {7571--7583},
  doi = {10.2147/jir.s520404}
}
Kostenlos starten →